We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Repurposed Drug Could Open Door to More Stem Cell Transplants

News   Dec 21, 2017 | Original story from University of British Columbia

 
Repurposed Drug Could Open Door to More Stem Cell Transplants

This is Peter Zandstra, director of UBC's School of Biomedical Engineering and Michael Smith Laboratories, and chief scientific officer of the Centre for Commercialization of Regenerative Medicine. Credit: UBC/Paul Joseph

 
 
 

RELATED ARTICLES

Fighting the Good Fight

News

Blocking an important enzyme in staphylococcal metabolism in a targeted manner would allow the pathogens to be starved.

READ MORE

Inflammation-blocking Inhibitor Could Treat Sepsis Too

News

A new inhibitor which decreases lung inflammation could hold the key to treating Acute Respiratory Distress Syndrome and sepsis.

READ MORE

Gene Editing Dramatically Improves Inherited Kidney Disease in Mice

News

Gene editing could be used to stop kidney damage in patients who have Joubert syndrome, an inherited kidney disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE